HPV E6/E7 mRNA与HPV-DNA检测技术在宫颈病变筛查中的诊断效度比较

被引:7
作者
沈丽蕊
游平弟
毛瑛玉
王海月
吴秋珍
韦翠花
机构
[1] 福建医科大学附属闽东医院
关键词
HPV E6/E7 mRNA检测; HPV-DNA检测; 宫颈癌前病变; 效度;
D O I
10.14033/j.cnki.cfmr.2017.29.037
中图分类号
R711.74 [子宫及子宫颈疾病]; R737.33 [子宫肿瘤];
学科分类号
100211 ; 100214 ;
摘要
目的:比较HPV E6/E7 mRNA与HPV-DNA两种检测技术在宫颈病变筛查中的临床效度。方法:回顾性分析笔者所在医院妇产科门诊在笔者所在科行HPV检测并行组织活检病理学检查的患者826例,其中HPV E6/E7 mRNA组420例,HPV-DNA组406例,比较两组方法在筛查CIN1及以上病变的阳性率、灵敏度、特异度。结果:两种方法在筛查CIN1及以上病变的阳性率的效果相当,两组间阳性率比较差异无统计学意义(P>0.05),而HPV E6/E7 mRNA检测组的灵敏度(96.1%)高于HPV-DNA组(90.9%),特异度(89.4%)明显高于HPV-DNA组(71.4%),两组间灵敏度及特异度比较,差异有统计学意义(P<0.05)。结论:HPV E6/E7 mRNA作为一种新型的检测技术,其假阳性率低,结果更靠性切实,更能精准地筛查宫颈癌前病变,值得临床推广应用。
引用
收藏
页码:75 / 77
页数:3
相关论文
共 7 条
[1]   液基薄层细胞学检测联合人乳头瘤病毒基因分型检测在宫颈病变筛查中的应用价值评估 [J].
毕雪玲 ;
张福梅 .
中国性科学, 2013, 22 (08) :28-30+36
[2]   基因第二代杂交捕获技术在宫颈癌筛查中的应用 [J].
余剑敏 ;
李海川 .
中国药物与临床, 2009, 9 (01) :46-48
[3]  
Distribution of human papilloma virus type 16 E6/E7 gene mutation in cervical precancer or cancer: A case control study in Guizhou Province, China [J] . Yingjie Yang,Jie Ren,Qizhu Zhang.&nbsp&nbspJ. Med. Virol. . 2016 (2)
[4]  
Comprehensive Control of Human Papillomavirus Infections and Related Diseases [J] . F. Xavier Bosch,Thomas R. Broker,David Forman,Anna-Barbara Moscicki,Maura L. Gillison,John Doorbar,Peter L. Stern,Margaret Stanley,Marc Arbyn,Mario Poljak,Jack Cuzick,Philip E. Castle,John T. Schiller,Lauri E. Markowitz,William A. Fisher,Karen Canfell,Lynette A. Denny,Eduardo L. Franco,Marc Steben,Mark A. Kane,Mark Schiffman,Chris J.L.M. Meijer,Rengaswamy Sankaranarayanan,Xavier Castellsagué,
[5]   Human papillomavirus and cervical cancer [J].
Crosbie, Emma J. ;
Einstein, Mark H. ;
Franceschi, Silvia ;
Kitchener, Henry C. .
LANCET, 2013, 382 (9895) :889-899
[6]   Metabolic Response on Post-therapy FDG-PET Predicts Patterns of Failure After Radiotherapy for Cervical Cancer [J].
Schwarz, Julie K. ;
Siegel, Barry A. ;
Dehdashti, Farrokh ;
Grigsby, Perry W. .
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2012, 83 (01) :185-190
[7]  
E6/E7 mRNA expression analysis: A test for the objective assessmentof cervical adenocarcinoma in clinical prognostic procedure [J] . Siri Hovland,Susanne Muller,Hanne Skomedal,Michael Mints,Jakob Bergstr?m,Keng-Ling Wallin,Frank Karlsen,Bo Johansson,Sonia Andersson.&nbsp&nbspInternational Journal of Oncology . 2010 (6)